Source: International Congress 2019 – Tuberculosis: treatment and management
Disease area: Respiratory infections, Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
T. Bagdasaryan (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation). Frequency of relapse rates in rifampicin-resistant tuberculosis in operated patients.. 5276

Member's Comments

No comment yet.

Related content which might interest you: Recurrence after successful treatment among patients with multidrug-resistant tuberculosis Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011 Prevalence of MDR and XDR tuberculosis among patients with failure of re-treatment course Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008 Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment Source: Eur Respir J 2003; 21: 478-482 Year: 2003 The characteristics of previous tuberculosis treatment programmes in patients with tuberculosis relapses Source: Eur Respir J 2001; 18: Suppl. 33, 473s Year: 2001 Evaluation of relapse and defaulter pulmonary tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 647s Year: 2005 Shorter treatment duration for selected patients with multidrug-resistant tuberculosis Source: Eur Respir J 2011; 37: 227-230 Year: 2011 Reevaluation of treatment outcome of relapse and defaulter pulmonary tuberculosis cases Source: Eur Respir J 2004; 24: Suppl. 48, 650s Year: 2004 Predictors of treatment outcome in multidrug-resistant tuberculosis Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011 Timing of relapse of tuberculosis in people with co-infection (HIV/TB) Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020 Predictors of treatment outcome in multidrug-resistant tuberculosis in Portugal Source: Eur Respir J 2013; 42: 1747-1749 Year: 2013 The incidence of multi drug resistant tuberculosis among patients receiving standardized treatment regimen for suspected MDR-TB Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012 Management of multidrug-resistant tuberculosis and patients in retreatment Source: Eur Respir J 2005; 25: 928-936 Year: 2005 Duration of hospitalization of patients treated for tuberculosis Source: Annual Congress 2010 - Global tuberculosis control Year: 2010 Multi-drug resistant tuberculosis: a retrospective analysis of cases over 10 years in a low incidence setting Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007 A multicentric cohort analysis of culture conversion and reversion in multidrug resistant tuberculosis (MDRTB) patients Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights Year: 2013 Treatment outcomes of extensively-drug resistant tuberculosis (XDR-TB) patients in 20 countries Source: Annual Congress 2012 - Pros and cons of MDR- and XDR-TB treatment Year: 2012 Detection of NTM in surgery samples from patients hospitalized with presumed TB Source: International Congress 2019 – Tuberculosis: diagnosis and scores Year: 2019 Analysis of loss to follow-up in 4099 multidrug-resistant pulmonary tuberculosis patients Source: Eur Respir J, 54 (1) 1800353; 10.1183/13993003.00353-2018 Year: 2019 Treatment effectiveness among newly detected patients with polyresistant tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 651s Year: 2005